Contribution of hypoxia-measuring molecular imaging techniques to radiotherapy planning and treatment.
Hypoxia is related to poor prognosis because it is associated to chemo- and radioresistance. During recent years the evolution of imaging methods like PET/CT and MRI has meant the appearance of new perspectives with direct implications in radiation therapy. We discuss previous experiences in staging, planning and in the follow-up process with these techniques for measuring tumour hypoxia.
Ferrer Albiach
Carlos
C
Servicio de Oncología Radioterápica, Consorcio Hospitalario Provincial de Castellón, Castellón, Spain. ferreralbiach@gmail.com
Conde Moreno
Antonio
A
Rodríguez Cordón
Marta
M
Morillo Macías
Virginia
V
Bouché Babiloni
Ana
A
Beato Tortajada
Inmaculada
I
Sánchez Iglesias
Angel
A
Francés Muñoz
Alicia
A
D000818:Animals; D014408:Biomarkers, Tumor / Q000235:genetics / Q000378:metabolism; D019788:Fluorodeoxyglucose F18; D006801:Humans; D000860:Hypoxia / Q000235:genetics / Q000378:metabolism*; D007150:Immunohistochemistry; D057054:Molecular Imaging / Q000379:methods*; D009369:Neoplasms / Q000175:diagnosis / Q000378:metabolism / Q000532:radiotherapy* / Q000628:therapy*; D049268:Positron-Emission Tomography / Q000379:methods; D011379:Prognosis; D011880:Radiotherapy Planning, Computer-Assisted / Q000379:methods*; D014057:Tomography, X-Ray Computed / Q000379:methods
D014408:Biomarkers, Tumor; D019788:Fluorodeoxyglucose F18